Review



csf3  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems csf3
    Figure 9. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by <t>ELISA.</t> Peyer’s patches of macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.
    Csf3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 80 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/Mouse+G-CSF+Quantikine+ELISA+Kit/pm40141330-598-50-58
    Average 93 stars, based on 80 article reviews
    csf3 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Modulation of Macrophages TLR4-Mediated Transcriptional Response by Lacticaseibacillus rhamnosus CRL1505 and Lactiplantibacillus plantarum CRL1506."

    Article Title: Modulation of Macrophages TLR4-Mediated Transcriptional Response by Lacticaseibacillus rhamnosus CRL1505 and Lactiplantibacillus plantarum CRL1506.

    Journal: International journal of molecular sciences

    doi: 10.3390/ijms26062688

    Figure 9. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches of macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.
    Figure Legend Snippet: Figure 9. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches of macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Techniques Used: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 10. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.
    Figure Legend Snippet: Figure 10. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Techniques Used: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 11. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.
    Figure Legend Snippet: Figure 11. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Techniques Used: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 12. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.
    Figure Legend Snippet: Figure 12. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Techniques Used: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma
    Article Snippet: .. Double-blinded quantitative detection of IFN-γ and CSF3 were performed using the mouse IFN-γ ELISA kit (R&D Systems, USA) and CSF3 ELISA kit (R&D Systems, USA) according to the manufacturer’s instructions. ..



    Similar Products

    94
    ATCC mouse csf3 elisa kit jonlnbio cat
    Mouse Csf3 Elisa Kit Jonlnbio Cat, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/Lactobacillus+leichmannii+(Henneberg)+Bergey+et+al/pm41650952-489-47-74
    Average 94 stars, based on 1 article reviews
    mouse csf3 elisa kit jonlnbio cat - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Multi Sciences (Lianke) Biotech Co Ltd csf3
    PPARα acts as an upstream positive regulator of FADS2 in psoriatic keratinocytes. A) RT‐qPCR analysis of PPARA expression in normal skin from healthy controls (NN, n = 4) and lesional skin tissue from psoriasis patients (PS, n = 5). B) Representative immunofluorescence images of PPARα and K14 co‐staining in normal skin from healthy controls and lesional skin tissue from psoriasis patients. C) RT‐qPCR analysis of PPARA in psoriatic lesional skin before and 10 weeks after infliximab treatment (n = 5). D) Representative images of PPARα immunofluorescence staining in lesional skin from psoriasis patients at baseline and week 10 following infliximab treatment. E) Representative immunofluorescence images of PPARα staining in healthy skin from control mice and skin lesions from IMQ‐induced psoriasis mouse model. F,G) RT‐qPCR analysis of PPARA (F) and FADS2 (G) expression in HaCaT cells stimulated with M5 for 12 h (n = 3). H) Immunoblotting of PPARα and FADS2 in HaCaT cells stimulated with M5 cytokines for the indicated time. I) RT‐qPCR analysis of PPARA , FADS2 , and indicated genes in HaCaT cells transfected with PPARA siRNA (si PPARA ) and control siRNA (siNC) for 24 h, followed by PBS or M5 stimulation for 12 h (n = 3). J) RT‐qPCR analysis of FADS2 and indicated genes in HaCaT cells pretreated with WY14643 or DMSO for 21 h, followed by PBS or M5 stimulation for 3 h (n = 3). K) ELISA quantification of CXCL1, CXCL8, and <t>CSF3</t> protein levels in cell lysates and supernatants from HaCaT cells treated as in (J) (n = 3). L) RT‐qPCR analysis of the indicated genes in HaCaT cells transfected with si FADS2 and siNC for 24 h, followed by M5 stimulation for 3 h before WY14643 or DMSO pretreatment (n = 3). Scale bar, 50 µm. Data are presented as mean ± SD. Statistical significance was determined by unpaired two‐tailed Student's t test (A,F,G,K), paired two‐tailed Student's t test (C), or one‐way ANOVA (I,J,L). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, not significant.
    Csf3, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/Human+G-CSF+ELISA+Kit/pmc12561275-266-4-24
    Average 94 stars, based on 1 article reviews
    csf3 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    Thermo Fisher mouse csf3 (g-csf) elisa kit
    PPARα acts as an upstream positive regulator of FADS2 in psoriatic keratinocytes. A) RT‐qPCR analysis of PPARA expression in normal skin from healthy controls (NN, n = 4) and lesional skin tissue from psoriasis patients (PS, n = 5). B) Representative immunofluorescence images of PPARα and K14 co‐staining in normal skin from healthy controls and lesional skin tissue from psoriasis patients. C) RT‐qPCR analysis of PPARA in psoriatic lesional skin before and 10 weeks after infliximab treatment (n = 5). D) Representative images of PPARα immunofluorescence staining in lesional skin from psoriasis patients at baseline and week 10 following infliximab treatment. E) Representative immunofluorescence images of PPARα staining in healthy skin from control mice and skin lesions from IMQ‐induced psoriasis mouse model. F,G) RT‐qPCR analysis of PPARA (F) and FADS2 (G) expression in HaCaT cells stimulated with M5 for 12 h (n = 3). H) Immunoblotting of PPARα and FADS2 in HaCaT cells stimulated with M5 cytokines for the indicated time. I) RT‐qPCR analysis of PPARA , FADS2 , and indicated genes in HaCaT cells transfected with PPARA siRNA (si PPARA ) and control siRNA (siNC) for 24 h, followed by PBS or M5 stimulation for 12 h (n = 3). J) RT‐qPCR analysis of FADS2 and indicated genes in HaCaT cells pretreated with WY14643 or DMSO for 21 h, followed by PBS or M5 stimulation for 3 h (n = 3). K) ELISA quantification of CXCL1, CXCL8, and <t>CSF3</t> protein levels in cell lysates and supernatants from HaCaT cells treated as in (J) (n = 3). L) RT‐qPCR analysis of the indicated genes in HaCaT cells transfected with si FADS2 and siNC for 24 h, followed by M5 stimulation for 3 h before WY14643 or DMSO pretreatment (n = 3). Scale bar, 50 µm. Data are presented as mean ± SD. Statistical significance was determined by unpaired two‐tailed Student's t test (A,F,G,K), paired two‐tailed Student's t test (C), or one‐way ANOVA (I,J,L). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, not significant.
    Mouse Csf3 (G Csf) Elisa Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/primers+probes+csf3+mm00438335+m1/pmc11044677-116-13-18
    Average 90 stars, based on 1 article reviews
    mouse csf3 (g-csf) elisa kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Dakewe Biotech Co human csf3 elisa kit
    PPARα acts as an upstream positive regulator of FADS2 in psoriatic keratinocytes. A) RT‐qPCR analysis of PPARA expression in normal skin from healthy controls (NN, n = 4) and lesional skin tissue from psoriasis patients (PS, n = 5). B) Representative immunofluorescence images of PPARα and K14 co‐staining in normal skin from healthy controls and lesional skin tissue from psoriasis patients. C) RT‐qPCR analysis of PPARA in psoriatic lesional skin before and 10 weeks after infliximab treatment (n = 5). D) Representative images of PPARα immunofluorescence staining in lesional skin from psoriasis patients at baseline and week 10 following infliximab treatment. E) Representative immunofluorescence images of PPARα staining in healthy skin from control mice and skin lesions from IMQ‐induced psoriasis mouse model. F,G) RT‐qPCR analysis of PPARA (F) and FADS2 (G) expression in HaCaT cells stimulated with M5 for 12 h (n = 3). H) Immunoblotting of PPARα and FADS2 in HaCaT cells stimulated with M5 cytokines for the indicated time. I) RT‐qPCR analysis of PPARA , FADS2 , and indicated genes in HaCaT cells transfected with PPARA siRNA (si PPARA ) and control siRNA (siNC) for 24 h, followed by PBS or M5 stimulation for 12 h (n = 3). J) RT‐qPCR analysis of FADS2 and indicated genes in HaCaT cells pretreated with WY14643 or DMSO for 21 h, followed by PBS or M5 stimulation for 3 h (n = 3). K) ELISA quantification of CXCL1, CXCL8, and <t>CSF3</t> protein levels in cell lysates and supernatants from HaCaT cells treated as in (J) (n = 3). L) RT‐qPCR analysis of the indicated genes in HaCaT cells transfected with si FADS2 and siNC for 24 h, followed by M5 stimulation for 3 h before WY14643 or DMSO pretreatment (n = 3). Scale bar, 50 µm. Data are presented as mean ± SD. Statistical significance was determined by unpaired two‐tailed Student's t test (A,F,G,K), paired two‐tailed Student's t test (C), or one‐way ANOVA (I,J,L). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, not significant.
    Human Csf3 Elisa Kit, supplied by Dakewe Biotech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/human+csf+3+elisa+kit/pm40185722-262-13-18
    Average 90 stars, based on 1 article reviews
    human csf3 elisa kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    R&D Systems csf3
    Figure 9. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by <t>ELISA.</t> Peyer’s patches of macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.
    Csf3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/Mouse+G-CSF+Quantikine+ELISA+Kit/pm40141330-598-50-58
    Average 93 stars, based on 1 article reviews
    csf3 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    R&D Systems csf3 elisa kit

    Csf3 Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/csf3+elisa+kit/pmc10897610-364-19-22
    Average 90 stars, based on 1 article reviews
    csf3 elisa kit - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    96
    R&D Systems mif00 csf3 elisa kit r d systems

    Mif00 Csf3 Elisa Kit R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/Mouse+IFN-gamma+Quantikine+ELISA+Kit/pmc10897610__mmc6-404-77-81
    Average 96 stars, based on 1 article reviews
    mif00 csf3 elisa kit r d systems - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    93
    Boster Bio csf3
    FIGURE 6 Levels of IL-6, <t>CSF3,</t> MMP8, and S100A8 and ROC curves of S100A8 and MMP8 in the peripheral blood of SAE patients. (A) When compared to the non-SAE (n=10) group, the SAE patients (n=21) had higher serum levels of MMP8 and S100A8 (both p<0.0). (B) High diagnostic accuracy was shown for the identification of SAE by both S100A8 (AUC = 0.962, 95% CI = 0.9001-1.000) and MMP8 (AUC = 0.7905, 95% CI = 0.6245-0.9564), with S100A8 having the highest accuracy. (C, D) Correlation analysis of the four extracellular molecules with clinical indicators and prognostic markers. S100A8, MMP8, CSF3, and IL-6 protein levels in the peripheral blood of sepsis patients were significantly linked with GCS scores (all p<0.05). S100A8 levels and 28-day mortality were strongly associated (r=0.634, p<0.01), and IL-6 levels and duration of mechanical breathing were positively correlated (r=0.360, p=0.046). *p <0.05, **p <0.01, ****p <0.0001; ns, no significance.
    Csf3, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/csf3+elisa+kit/Human+G-CSF+ELISA+Kit+PicoKine/pm37901226-126-47-50
    Average 93 stars, based on 1 article reviews
    csf3 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    PPARα acts as an upstream positive regulator of FADS2 in psoriatic keratinocytes. A) RT‐qPCR analysis of PPARA expression in normal skin from healthy controls (NN, n = 4) and lesional skin tissue from psoriasis patients (PS, n = 5). B) Representative immunofluorescence images of PPARα and K14 co‐staining in normal skin from healthy controls and lesional skin tissue from psoriasis patients. C) RT‐qPCR analysis of PPARA in psoriatic lesional skin before and 10 weeks after infliximab treatment (n = 5). D) Representative images of PPARα immunofluorescence staining in lesional skin from psoriasis patients at baseline and week 10 following infliximab treatment. E) Representative immunofluorescence images of PPARα staining in healthy skin from control mice and skin lesions from IMQ‐induced psoriasis mouse model. F,G) RT‐qPCR analysis of PPARA (F) and FADS2 (G) expression in HaCaT cells stimulated with M5 for 12 h (n = 3). H) Immunoblotting of PPARα and FADS2 in HaCaT cells stimulated with M5 cytokines for the indicated time. I) RT‐qPCR analysis of PPARA , FADS2 , and indicated genes in HaCaT cells transfected with PPARA siRNA (si PPARA ) and control siRNA (siNC) for 24 h, followed by PBS or M5 stimulation for 12 h (n = 3). J) RT‐qPCR analysis of FADS2 and indicated genes in HaCaT cells pretreated with WY14643 or DMSO for 21 h, followed by PBS or M5 stimulation for 3 h (n = 3). K) ELISA quantification of CXCL1, CXCL8, and CSF3 protein levels in cell lysates and supernatants from HaCaT cells treated as in (J) (n = 3). L) RT‐qPCR analysis of the indicated genes in HaCaT cells transfected with si FADS2 and siNC for 24 h, followed by M5 stimulation for 3 h before WY14643 or DMSO pretreatment (n = 3). Scale bar, 50 µm. Data are presented as mean ± SD. Statistical significance was determined by unpaired two‐tailed Student's t test (A,F,G,K), paired two‐tailed Student's t test (C), or one‐way ANOVA (I,J,L). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, not significant.

    Journal: Advanced Science

    Article Title: Reprogramming of Fatty Acid Metabolism via PPARα‐Orchestrated FADS2 in Keratinocytes Modulates Skin Inflammation in Psoriasis

    doi: 10.1002/advs.202417049

    Figure Lengend Snippet: PPARα acts as an upstream positive regulator of FADS2 in psoriatic keratinocytes. A) RT‐qPCR analysis of PPARA expression in normal skin from healthy controls (NN, n = 4) and lesional skin tissue from psoriasis patients (PS, n = 5). B) Representative immunofluorescence images of PPARα and K14 co‐staining in normal skin from healthy controls and lesional skin tissue from psoriasis patients. C) RT‐qPCR analysis of PPARA in psoriatic lesional skin before and 10 weeks after infliximab treatment (n = 5). D) Representative images of PPARα immunofluorescence staining in lesional skin from psoriasis patients at baseline and week 10 following infliximab treatment. E) Representative immunofluorescence images of PPARα staining in healthy skin from control mice and skin lesions from IMQ‐induced psoriasis mouse model. F,G) RT‐qPCR analysis of PPARA (F) and FADS2 (G) expression in HaCaT cells stimulated with M5 for 12 h (n = 3). H) Immunoblotting of PPARα and FADS2 in HaCaT cells stimulated with M5 cytokines for the indicated time. I) RT‐qPCR analysis of PPARA , FADS2 , and indicated genes in HaCaT cells transfected with PPARA siRNA (si PPARA ) and control siRNA (siNC) for 24 h, followed by PBS or M5 stimulation for 12 h (n = 3). J) RT‐qPCR analysis of FADS2 and indicated genes in HaCaT cells pretreated with WY14643 or DMSO for 21 h, followed by PBS or M5 stimulation for 3 h (n = 3). K) ELISA quantification of CXCL1, CXCL8, and CSF3 protein levels in cell lysates and supernatants from HaCaT cells treated as in (J) (n = 3). L) RT‐qPCR analysis of the indicated genes in HaCaT cells transfected with si FADS2 and siNC for 24 h, followed by M5 stimulation for 3 h before WY14643 or DMSO pretreatment (n = 3). Scale bar, 50 µm. Data are presented as mean ± SD. Statistical significance was determined by unpaired two‐tailed Student's t test (A,F,G,K), paired two‐tailed Student's t test (C), or one‐way ANOVA (I,J,L). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001; ns, not significant.

    Article Snippet: Similarly, human CXCL1 (#70‐EK196), CSF3 (#70‐EK169), and CXCL8 (#70‐EK108/2) levels in cultured human keratinocyte lysates and supernatants were measured using corresponding human ELISA kits (Lianke Bio, China) according to the provided protocols.

    Techniques: Quantitative RT-PCR, Expressing, Immunofluorescence, Staining, Control, Western Blot, Transfection, Enzyme-linked Immunosorbent Assay, Two Tailed Test

    Figure 9. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches of macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Journal: International journal of molecular sciences

    Article Title: Modulation of Macrophages TLR4-Mediated Transcriptional Response by Lacticaseibacillus rhamnosus CRL1505 and Lactiplantibacillus plantarum CRL1506.

    doi: 10.3390/ijms26062688

    Figure Lengend Snippet: Figure 9. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches of macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Article Snippet: 2025, 26, 2688 22 of 26 BMS614) and IL-12 (Mouse IL-12 p70 ELISA Kit, BMS6004) from ThermoFisher Scientific (Waltham, MA, USA), and CCL-2 (Mouse CCL2/JE/MCP-1 ELISA Kit Quantikine, MJE00B), CCL-8 (Mouse CCL8/MCP-2 DuoSet ELISA, DY790), IL-27 (Mouse IL-27 p28/IL-30 ELISA Kit Quantikine, M2728), CSF2 (Mouse GM-CSF DuoSet ELISA, DY415), and CSF3 (Mouse G-CSF ELISA Kit Quantikine, MCS00) from R&D Systems (Minneapolis, MN, USA).

    Techniques: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 10. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Journal: International journal of molecular sciences

    Article Title: Modulation of Macrophages TLR4-Mediated Transcriptional Response by Lacticaseibacillus rhamnosus CRL1505 and Lactiplantibacillus plantarum CRL1506.

    doi: 10.3390/ijms26062688

    Figure Lengend Snippet: Figure 10. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine Peyer’s patches macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticaseibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, Peyer’s patches macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peyer’s patches macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Article Snippet: 2025, 26, 2688 22 of 26 BMS614) and IL-12 (Mouse IL-12 p70 ELISA Kit, BMS6004) from ThermoFisher Scientific (Waltham, MA, USA), and CCL-2 (Mouse CCL2/JE/MCP-1 ELISA Kit Quantikine, MJE00B), CCL-8 (Mouse CCL8/MCP-2 DuoSet ELISA, DY790), IL-27 (Mouse IL-27 p28/IL-30 ELISA Kit Quantikine, M2728), CSF2 (Mouse GM-CSF DuoSet ELISA, DY415), and CSF3 (Mouse G-CSF ELISA Kit Quantikine, MCS00) from R&D Systems (Minneapolis, MN, USA).

    Techniques: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 11. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Journal: International journal of molecular sciences

    Article Title: Modulation of Macrophages TLR4-Mediated Transcriptional Response by Lacticaseibacillus rhamnosus CRL1505 and Lactiplantibacillus plantarum CRL1506.

    doi: 10.3390/ijms26062688

    Figure Lengend Snippet: Figure 11. Effect of lactobacilli strains on the production of inflammatory cytokines and chemokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Article Snippet: 2025, 26, 2688 22 of 26 BMS614) and IL-12 (Mouse IL-12 p70 ELISA Kit, BMS6004) from ThermoFisher Scientific (Waltham, MA, USA), and CCL-2 (Mouse CCL2/JE/MCP-1 ELISA Kit Quantikine, MJE00B), CCL-8 (Mouse CCL8/MCP-2 DuoSet ELISA, DY790), IL-27 (Mouse IL-27 p28/IL-30 ELISA Kit Quantikine, M2728), CSF2 (Mouse GM-CSF DuoSet ELISA, DY415), and CSF3 (Mouse G-CSF ELISA Kit Quantikine, MCS00) from R&D Systems (Minneapolis, MN, USA).

    Techniques: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Figure 12. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Journal: International journal of molecular sciences

    Article Title: Modulation of Macrophages TLR4-Mediated Transcriptional Response by Lacticaseibacillus rhamnosus CRL1505 and Lactiplantibacillus plantarum CRL1506.

    doi: 10.3390/ijms26062688

    Figure Lengend Snippet: Figure 12. Effect of lactobacilli strains on the production of inflammatory and regulatory cytokines by murine peritoneal macrophages stimulated with the Toll-like receptor 4 (TLR4) agonist lipopolysac- charide (LPS). Immunocompetent adult BALB/c mice (6 weeks) were orally treated with Lacticas- eibacillus rhamnosus CRL1505 or Lactiplantibacillus plantarum CRL1506 strains for five days. On day 6, peritoneal macrophages were isolated, cultured for 24 h, and then challenged with LPS. The levels of cytokines were determined after 24 h of culture (basal) or 24 h after LPS challenge by ELISA. Peritoneal macrophages obtained from non-lactobacilli-treated mice were used as controls. Asterisks indicate significant differences between the indicated groups and basal or LPS-challenged controls, (*) p < 0.05; (**) p < 0.01.

    Article Snippet: 2025, 26, 2688 22 of 26 BMS614) and IL-12 (Mouse IL-12 p70 ELISA Kit, BMS6004) from ThermoFisher Scientific (Waltham, MA, USA), and CCL-2 (Mouse CCL2/JE/MCP-1 ELISA Kit Quantikine, MJE00B), CCL-8 (Mouse CCL8/MCP-2 DuoSet ELISA, DY790), IL-27 (Mouse IL-27 p28/IL-30 ELISA Kit Quantikine, M2728), CSF2 (Mouse GM-CSF DuoSet ELISA, DY415), and CSF3 (Mouse G-CSF ELISA Kit Quantikine, MCS00) from R&D Systems (Minneapolis, MN, USA).

    Techniques: Isolation, Cell Culture, Enzyme-linked Immunosorbent Assay

    Journal: Cell Reports Medicine

    Article Title: Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma

    doi: 10.1016/j.xcrm.2024.101415

    Figure Lengend Snippet:

    Article Snippet: Double-blinded quantitative detection of IFN-γ and CSF3 were performed using the mouse IFN-γ ELISA kit (R&D Systems, USA) and CSF3 ELISA kit (R&D Systems, USA) according to the manufacturer’s instructions.

    Techniques: Virus, Recombinant, Red Blood Cell Lysis, Enzyme-linked Immunosorbent Assay, CCK-8 Assay, Isolation, Multiple Displacement Amplification, Expressing, shRNA, Software

    FIGURE 6 Levels of IL-6, CSF3, MMP8, and S100A8 and ROC curves of S100A8 and MMP8 in the peripheral blood of SAE patients. (A) When compared to the non-SAE (n=10) group, the SAE patients (n=21) had higher serum levels of MMP8 and S100A8 (both p<0.0). (B) High diagnostic accuracy was shown for the identification of SAE by both S100A8 (AUC = 0.962, 95% CI = 0.9001-1.000) and MMP8 (AUC = 0.7905, 95% CI = 0.6245-0.9564), with S100A8 having the highest accuracy. (C, D) Correlation analysis of the four extracellular molecules with clinical indicators and prognostic markers. S100A8, MMP8, CSF3, and IL-6 protein levels in the peripheral blood of sepsis patients were significantly linked with GCS scores (all p<0.05). S100A8 levels and 28-day mortality were strongly associated (r=0.634, p<0.01), and IL-6 levels and duration of mechanical breathing were positively correlated (r=0.360, p=0.046). *p <0.05, **p <0.01, ****p <0.0001; ns, no significance.

    Journal: Frontiers in immunology

    Article Title: Extracellular proteins as potential biomarkers in Sepsis-related cerebral injury.

    doi: 10.3389/fimmu.2023.1128476

    Figure Lengend Snippet: FIGURE 6 Levels of IL-6, CSF3, MMP8, and S100A8 and ROC curves of S100A8 and MMP8 in the peripheral blood of SAE patients. (A) When compared to the non-SAE (n=10) group, the SAE patients (n=21) had higher serum levels of MMP8 and S100A8 (both p<0.0). (B) High diagnostic accuracy was shown for the identification of SAE by both S100A8 (AUC = 0.962, 95% CI = 0.9001-1.000) and MMP8 (AUC = 0.7905, 95% CI = 0.6245-0.9564), with S100A8 having the highest accuracy. (C, D) Correlation analysis of the four extracellular molecules with clinical indicators and prognostic markers. S100A8, MMP8, CSF3, and IL-6 protein levels in the peripheral blood of sepsis patients were significantly linked with GCS scores (all p<0.05). S100A8 levels and 28-day mortality were strongly associated (r=0.634, p<0.01), and IL-6 levels and duration of mechanical breathing were positively correlated (r=0.360, p=0.046). *p <0.05, **p <0.01, ****p <0.0001; ns, no significance.

    Article Snippet: The levels of IL6, MMP8, CSF3, and S100A8 were determined by the following commercial ELISA kits, according to manufacturer’s recommendations: MMP8 (Cat.#CSB-E04680h, Cusabio Biotech Co. Ltd, Wuhan, China), S100A8 (Cat. #CSB-E11833h, Cusabio Biotech Co. Ltd, Wuhan, China), IL-6 (Cat. #CSB-E04638h, Cusabio Biotech Co. Ltd, Wuhan, China), and CSF3 (Cat. #EK0360, Boster Biotech Co. Ltd, USA).

    Techniques: Diagnostic Assay